Keros Therapeutics, Inc. Public Float
Keros Therapeutics, Inc. (KROS) had Public Float of $453.00 million as of 2025-06-30, per its 10-K filed 2026-03-04.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-04
- 2025-06-30: Entity Public Float $453.00M.
- 2024-06-28: Entity Public Float $1.30B.
- 2023-06-30: Entity Public Float $905.30M.
- 2022-06-30: Entity Public Float $470.70M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $453.00M 10-K · filed 2026-03-04 |
| 2024-06-28 | $1.30B 10-K · filed 2025-02-26 |
| 2023-06-30 | $905.30M 10-K · filed 2024-02-28 |
| 2022-06-30 | $470.70M 10-K · filed 2023-03-03 |
| 2021-06-30 | $657.30M 10-K · filed 2022-03-09 |
| 2020-06-30 | $386.00M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |